• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problem Difficult to Open or Close (2921)
Patient Problems Thrombosis/Thrombus (4440); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/12/2021
Event Type  malfunction  
Event Description
On (b)(6) 2021, it was suspected that a valve thrombus have generated on a perceval valve that was implanted on (b)(6) 2021.This event was detected at the follow up performed on the patient.The patient is asymptomatic and was discharged from the hospital.There is no plan for re-intervention on the patient who is planned to follow up in 3 months.No further information regarding the device relationship was provided from the hospital.It is unknown if the patient has any coagulation disorders.On pod12, the tee showed that the ncc leaflet movement was restricted.Regarding the anticoagulation therapy, until pod12 the patient was receiving only warfarin, and the inr was controlled from 1.5 to 2.0.After pod12, warfarin and bayaspirin were administered, and inr was controlled more than 2.At the ct scan performed on pod7, halt was found at the base of the ncc (around the annulus).
 
Manufacturer Narrative
The manufacturing and material records for the perceval heart valve, model #icv1209, s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by quality engineering at corcym (b)(4) corp.The results confirmed that this valve satisfied all material, visual, and performance standards required for a (model #icv1209) perceval heart valve at the time of manufacture and release.Based on the information available, it is not possible to draw a definitive conclusion on the reported event.However, from the document review performed, no manufacturing deficits were identified.The manufacturer attempted to retrieve additional information on the clinical history and baseline conditions of the patient, as well as a medical judgment on the event, but no further information was provided.Should further information become available on this event, a follow up report will be provided.Device remains implanted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP
5005 north fraser way
burnaby, british columbia V5J5M 1
CA  V5J5M1
MDR Report Key11988061
MDR Text Key281167256
Report Number3004478276-2021-00170
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000429
UDI-Public(01)00896208000429(240)ICV1209(17)220702
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/02/2022
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 05/14/2021
Initial Date FDA Received06/11/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age77 YR
Patient Weight39
-
-